摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5-bromo-2-chloro-pyrimidin-4-yl)-(5-methanesulfonyl-thiophen-2-ylmethyl)-amine | 719313-59-4

中文名称
——
中文别名
——
英文名称
(5-bromo-2-chloro-pyrimidin-4-yl)-(5-methanesulfonyl-thiophen-2-ylmethyl)-amine
英文别名
5-bromo-2-chloro-N-[(5-methylsulfonylthiophen-2-yl)methyl]pyrimidin-4-amine
(5-bromo-2-chloro-pyrimidin-4-yl)-(5-methanesulfonyl-thiophen-2-ylmethyl)-amine化学式
CAS
719313-59-4
化学式
C10H9BrClN3O2S2
mdl
——
分子量
382.689
InChiKey
MCFUMXYZHPMBHI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    109
  • 氢给体数:
    1
  • 氢受体数:
    6

文献信息

  • Compound for the treatment of abnormal cell growth
    申请人:Pfizer Inc
    公开号:US20040220177A1
    公开(公告)日:2004-11-04
    The invention relates to compounds of the formula 1 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , n, A and B are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
    本发明涉及公式11的化合物,以及其药物可接受的盐、前药和溶剂化物,其中R1、R2、R3、R4、R5、n、A和B的定义如本文所述。本发明还涉及通过给予公式1的化合物治疗哺乳动物异常细胞生长的方法,并涉及用于治疗此类疾病的制药组合物,其中包含公式1的化合物。本发明还涉及制备公式1的化合物的方法。
  • PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH
    申请人:Pfizer Products Inc.
    公开号:EP1578732A2
    公开(公告)日:2005-09-28
  • [EN] COMPOUNDS FOR THE TREATMENT OF ABNORMAL CELL GROWTH<br/>[FR] COMPOSES POUR TRAITER LE DEVELOPPEMENT ANORMAL DE CELLULES
    申请人:PFIZER PROD INC
    公开号:WO2004056786A2
    公开(公告)日:2004-07-08
    The invention relates to compounds of the formula (1) and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1, R2, R3, R4, R5, n, A and B are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula (1) and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula (1). The invention also relates to methods of preparing the compounds of formula (1).
查看更多